1. Home
  2. NVAX vs RLJ Comparison

NVAX vs RLJ Comparison

Compare NVAX & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • RLJ
  • Stock Information
  • Founded
  • NVAX 1987
  • RLJ 2011
  • Country
  • NVAX United States
  • RLJ United States
  • Employees
  • NVAX N/A
  • RLJ N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • RLJ Real Estate Investment Trusts
  • Sector
  • NVAX Health Care
  • RLJ Real Estate
  • Exchange
  • NVAX Nasdaq
  • RLJ Nasdaq
  • Market Cap
  • NVAX 1.3B
  • RLJ 1.1B
  • IPO Year
  • NVAX 1995
  • RLJ 2011
  • Fundamental
  • Price
  • NVAX $7.84
  • RLJ $7.72
  • Analyst Decision
  • NVAX Hold
  • RLJ Hold
  • Analyst Count
  • NVAX 6
  • RLJ 6
  • Target Price
  • NVAX $15.00
  • RLJ $9.35
  • AVG Volume (30 Days)
  • NVAX 8.6M
  • RLJ 2.2M
  • Earning Date
  • NVAX 08-06-2025
  • RLJ 08-07-2025
  • Dividend Yield
  • NVAX N/A
  • RLJ 7.77%
  • EPS Growth
  • NVAX N/A
  • RLJ N/A
  • EPS
  • NVAX 2.54
  • RLJ 0.20
  • Revenue
  • NVAX $1,078,718,000.00
  • RLJ $1,367,020,000.00
  • Revenue This Year
  • NVAX $52.02
  • RLJ $0.81
  • Revenue Next Year
  • NVAX N/A
  • RLJ $1.59
  • P/E Ratio
  • NVAX $3.08
  • RLJ $38.76
  • Revenue Growth
  • NVAX 9.22
  • RLJ 1.40
  • 52 Week Low
  • NVAX $5.01
  • RLJ $6.16
  • 52 Week High
  • NVAX $15.22
  • RLJ $10.84
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 48.26
  • RLJ 58.97
  • Support Level
  • NVAX $7.57
  • RLJ $7.33
  • Resistance Level
  • NVAX $10.64
  • RLJ $7.46
  • Average True Range (ATR)
  • NVAX 0.72
  • RLJ 0.23
  • MACD
  • NVAX -0.07
  • RLJ 0.04
  • Stochastic Oscillator
  • NVAX 29.47
  • RLJ 96.53

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

Share on Social Networks: